NO983560L - Triazolderivater nyttige i terapi - Google Patents

Triazolderivater nyttige i terapi

Info

Publication number
NO983560L
NO983560L NO983560A NO983560A NO983560L NO 983560 L NO983560 L NO 983560L NO 983560 A NO983560 A NO 983560A NO 983560 A NO983560 A NO 983560A NO 983560 L NO983560 L NO 983560L
Authority
NO
Norway
Prior art keywords
therapy
triazole derivatives
derivatives useful
useful
triazole
Prior art date
Application number
NO983560A
Other languages
English (en)
Other versions
NO323771B1 (no
NO983560D0 (no
Inventor
Charles W Murtiashaw
Stuart Green
Peter T Stephenson
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of NO983560L publication Critical patent/NO983560L/no
Publication of NO983560D0 publication Critical patent/NO983560D0/no
Publication of NO323771B1 publication Critical patent/NO323771B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518—Five-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19983560A 1996-02-02 1998-08-03 Triazolderivater nyttige i terapi NO323771B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602080.5A GB9602080D0 (en) 1996-02-02 1996-02-02 Pharmaceutical compounds
PCT/EP1997/000445 WO1997028169A1 (en) 1996-02-02 1997-01-27 Triazole derivatives useful in therapy

Publications (3)

Publication Number Publication Date
NO983560L true NO983560L (no) 1998-08-03
NO983560D0 NO983560D0 (no) 1998-08-03
NO323771B1 NO323771B1 (no) 2007-07-02

Family

ID=10787975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983560A NO323771B1 (no) 1996-02-02 1998-08-03 Triazolderivater nyttige i terapi

Country Status (43)

Country Link
US (4) US6790957B2 (no)
EP (1) EP0880533B1 (no)
JP (1) JP2959846B2 (no)
KR (1) KR100283546B1 (no)
CN (1) CN1085213C (no)
AP (1) AP678A (no)
AT (1) ATE219089T1 (no)
AU (1) AU709781B2 (no)
BG (1) BG63946B1 (no)
BR (1) BR9707257A (no)
CA (1) CA2240777C (no)
CO (1) CO4761066A1 (no)
CZ (1) CZ291431B6 (no)
DE (1) DE69713284T2 (no)
DK (1) DK0880533T3 (no)
DZ (1) DZ2172A1 (no)
ES (1) ES2175336T3 (no)
GB (1) GB9602080D0 (no)
GT (1) GT199700016A (no)
HK (1) HK1018217A1 (no)
HN (1) HN1997000012A (no)
HR (1) HRP970063B1 (no)
HU (1) HU226133B1 (no)
ID (1) ID15858A (no)
IL (3) IL124865A (no)
IS (1) IS1995B (no)
MY (1) MY116849A (no)
NO (1) NO323771B1 (no)
NZ (1) NZ330654A (no)
OA (1) OA10711A (no)
PL (1) PL187237B1 (no)
PT (1) PT880533E (no)
RS (1) RS49526B (no)
RU (1) RU2176244C2 (no)
SA (1) SA97170578B1 (no)
SI (1) SI0880533T1 (no)
SK (1) SK283136B6 (no)
TN (1) TNSN97023A1 (no)
TR (1) TR199801440T2 (no)
TW (1) TW434247B (no)
UA (1) UA46828C2 (no)
WO (1) WO1997028169A1 (no)
ZA (1) ZA97826B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
DE19751525C2 (de) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak
US6265584B1 (en) 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
KR20010050557A (ko) * 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
US7540402B2 (en) * 2001-06-29 2009-06-02 Kva, Inc. Method for controlling weld metal microstructure using localized controlled cooling of seam-welded joints
US7323572B2 (en) 2002-07-16 2008-01-29 Pfizer Inc Process for controlling the hydrate mix of a compound
WO2005006860A2 (en) * 2003-07-18 2005-01-27 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Azole derivatives and methods for making the same
CN101132802A (zh) * 2004-03-24 2008-02-27 法斯根有限责任公司 通过药理学抑制amp-活化的蛋白激酶的神经保护的新方法
CN1303073C (zh) * 2005-05-31 2007-03-07 中国人民解放军第二军医大学 取代三唑酮苄胺三唑醇类抗真菌化合物及其制备方法
EP1964843B1 (en) * 2005-12-20 2013-08-28 Eisai R&D Management Co., Ltd. Process for production of water-soluble azole prodrug
US20100004206A1 (en) 2005-12-27 2010-01-07 Makoto Komatsu Water-soluble benzoazepine compound and its pharmaceutical composition
DE602007009489D1 (de) 2006-02-22 2010-11-11 Eisai R&D Man Co Ltd Stabilisierte pharmazeutische zusammensetzung
CL2009000902A1 (es) * 2008-04-15 2010-07-23 Merck Sharp & Dohme Composicion que comprende posaconazol disuelto o disperso molecularmente en un polimero derivado de hidroxipropilcelulosa; formulacion farmaceutica que comprende a la composion; un proceso para preparar a la composicion mediante fusioextrusion; y su uso para tratar una infeccion micotica.
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
JP6336902B2 (ja) 2011-06-22 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー．リミテッド コンジュゲートベースの抗真菌性および抗菌性プロドラッグ
EP2561863A1 (en) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmaceutical compositions comprising voriconazole
EP2804858B1 (en) 2012-01-20 2019-12-25 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
KR102236462B1 (ko) * 2012-03-19 2021-04-08 시다라 세라퓨틱스, 인코포레이티드 에키노칸딘 계열의 화합물에 대한 투여 용법
CN103864844B (zh) * 2012-12-09 2016-10-05 正大天晴药业集团股份有限公司 一种福司氟康唑的制备方法
CN103304600B (zh) * 2013-03-04 2018-05-25 陕西合成药业股份有限公司 一种伏立康唑磷酸酯三水合物及其制备方法和用途
EP2968595A2 (en) 2013-03-14 2016-01-20 Fresenius Kabi USA LLC Voriconazole formulations
RU2719579C2 (ru) * 2013-03-14 2020-04-21 Сидара Терапьютикс, Инк. Режимы дозирования для соединений класса эхинокандинов
KR101814895B1 (ko) 2013-06-04 2018-01-04 바이옴 바이오사이언스 피브이티. 엘티디. 코팅된 입자 및 이를 포함하는 조성물
CN103524560A (zh) * 2013-09-28 2014-01-22 陕西合成药业有限公司 伏立康磷酸酯钠水合物及其多晶型
CN104650140B (zh) * 2013-11-18 2017-11-10 正大天晴药业集团股份有限公司 一种高纯度福司氟康唑的制备方法
BR112016017690A2 (pt) 2014-01-29 2017-08-08 Vyome Biosciences Pvt Ltd Tratamentos para acne resistente
CN104860992A (zh) * 2014-02-25 2015-08-26 陕西合成药业股份有限公司 一种高纯度福司氟康唑制备方法
CN105985377A (zh) * 2015-02-09 2016-10-05 陕西合成药业股份有限公司 一种福司氟康唑盐水合物及其制备方法
CN106279280A (zh) * 2015-05-25 2017-01-04 西藏卫信康医药股份有限公司 一种化合物及其制备方法和应用
CN106518922A (zh) * 2015-09-12 2017-03-22 陕西合成药业股份有限公司 一种三唑类化合物及其制备方法和用途
CN106546668A (zh) * 2015-09-22 2017-03-29 陕西合成药业股份有限公司 一种分离福司氟康唑或其药用盐有关物质的hplc方法
CN105237569B (zh) * 2015-10-21 2017-07-25 西南科技大学 一种制备2，4‑二氟‑α，α‑二（1氢‑1，2，4‑三唑‑1‑基甲基）苯甲醇磷酸二苄酯的合成方法
CN105753902B (zh) * 2016-04-11 2017-08-25 浙江诚意药业股份有限公司 一种福司氟康唑的制备方法
CN108676031A (zh) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用
CN111171075B (zh) * 2020-04-03 2022-07-12 北京四环生物制药有限公司 一种福司氟康唑的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4528284A (en) * 1982-10-15 1985-07-09 Ciba-Geigy Corporation Fungicidal 2-(azolylmethyl-1'-yl)-2-aryl-2-(cyano, alkoxycarbonyl, alkylthiocarbonyl and aminocarbonyl)-2-phosphorus acid esters
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
TW211006B (no) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd
TW218017B (no) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
US5358939A (en) * 1992-06-25 1994-10-25 Rohm And Haas Company Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles
NZ278882A (en) * 1994-01-24 1997-06-24 Janssen Pharmaceutica Nv Piperazine-containing azole antifungal compounds
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
WO1995022973A1 (en) * 1994-02-25 1995-08-31 Takeda Chemicals Industries, Ltd. Injectable emulsions containing antifungal triazole derivatives
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
FR2741061B1 (fr) * 1995-11-13 1998-03-20 Alcatel Fibres Optiques Procede de fabrication d'une fibre optique monomode et amplificateur optique utilisant une telle fibre
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US5767977A (en) * 1996-12-19 1998-06-16 Hewlett-Packard Co. Method and apparatus for a carriage latch and power cord lock-out system for an optical scanner

Also Published As

Publication number Publication date
US20050130940A1 (en) 2005-06-16
BR9707257A (pt) 1999-04-06
IS4785A (is) 1998-06-26
AP9700923A0 (en) 1997-01-31
IL133135A0 (en) 2001-03-19
HK1018217A1 (en) 1999-12-17
UA46828C2 (uk) 2002-06-17
RS49526B (sr) 2006-12-15
ZA97826B (en) 1998-07-31
IL124865A0 (en) 1999-01-26
DZ2172A1 (fr) 2002-12-01
SI0880533T1 (en) 2002-08-31
GB9602080D0 (en) 1996-04-03
SK102298A3 (en) 1999-08-06
PL187237B1 (pl) 2004-06-30
US20070027115A1 (en) 2007-02-01
SK283136B6 (sk) 2003-03-04
SA97170578B1 (ar) 2006-01-28
US6977302B2 (en) 2005-12-20
AU1598597A (en) 1997-08-22
NZ330654A (en) 1999-08-30
TR199801440T2 (xx) 1998-10-21
HN1997000012A (es) 1997-06-26
YU2997A (sh) 2000-10-30
AP678A (en) 1998-09-28
PL328436A1 (en) 1999-02-01
DE69713284T2 (de) 2003-03-27
KR19990082233A (ko) 1999-11-25
KR100283546B1 (ko) 2001-04-02
GT199700016A (es) 1998-07-24
HU226133B1 (en) 2008-05-28
HRP970063B1 (en) 2001-12-31
US6790957B2 (en) 2004-09-14
HUP9900949A3 (en) 2001-08-28
ID15858A (id) 1997-08-14
DE69713284D1 (de) 2002-07-18
ATE219089T1 (de) 2002-06-15
BG102603A (en) 1999-03-31
US20030144250A1 (en) 2003-07-31
IL133135A (en) 2003-07-06
IL124865A (en) 2002-03-10
NO323771B1 (no) 2007-07-02
AU709781B2 (en) 1999-09-09
CZ291431B6 (cs) 2003-03-12
MY116849A (en) 2004-04-30
BG63946B1 (bg) 2003-07-31
OA10711A (en) 2001-06-04
WO1997028169A1 (en) 1997-08-07
EP0880533A1 (en) 1998-12-02
NO983560D0 (no) 1998-08-03
TW434247B (en) 2001-05-16
DK0880533T3 (da) 2002-07-15
PT880533E (pt) 2002-09-30
TNSN97023A1 (fr) 2005-03-15
JPH10512599A (ja) 1998-12-02
JP2959846B2 (ja) 1999-10-06
IS1995B (is) 2005-03-15
HRP970063A2 (en) 1998-06-30
CA2240777A1 (en) 1997-08-07
CN1210540A (zh) 1999-03-10
CA2240777C (en) 2002-06-11
ES2175336T3 (es) 2002-11-16
EP0880533B1 (en) 2002-06-12
CO4761066A1 (es) 1999-04-27
CN1085213C (zh) 2002-05-22
CZ242098A3 (cs) 1999-05-12
RU2176244C2 (ru) 2001-11-27
HUP9900949A2 (hu) 2001-05-28
US20040236105A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
NO983560L (no) Triazolderivater nyttige i terapi
FI970762A (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
BR9509805A (pt) Derivados de triazolila
GB9609641D0 (en) Compounds useful in therapy
BR9701593A (pt) Aperfeiçoamentos em eixos telescópicos
DE69634991D1 (de) Elektrotherapiegerät
GB9604400D0 (en) Compounds useful in therapy
SE9602645D0 (sv) Azabicyclic derivatives useful in therapy
GB9508784D0 (en) Triazole derivatives useful in therapy
BR7400430U (pt) Disposição introduzida em guarda-roupa
ID15951A (id) Senyawa dikarbamoil
FI1916U1 (fi) Anordning foer reglering av cirkelsaogsklingors in boerdes avstaond
FI1691U1 (fi) Hopsaettningsmaskin foer lastpallsben
BR7601911U (pt) Disposição introduzida em ceifador
BR7402351U (pt) Disposição introduzida em soroban
SE9600682D0 (sv) Spiroazabicyclic compounds useful in therayp
BR7600415U (pt) Disposição construtiva em bombona
BR7500457U (pt) Disposição construtiva em forma-embalagem
BR7501145U (pt) Disposição construtiva em pingete
BR9604585A (pt) Aperfeiçoamento introduzida em mini-cervejaria
BR7402429U (pt) Disposição introduzida em armazém
BR7601811U (pt) Disposição introduzida em fralda
BR9502286A (pt) Aperfeiçoamentos introduzidos em terraceador
BR7601298U (pt) Disposiçao construtiva em sauna residencial
KR960009818U (ko) 사물함

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees